Week 10-12: Gastrointestinal Tract Flashcards

(245 cards)

1
Q

Which Inflammatory Bowel Disease is characterized by bloody stool?

A

Ulcerative Colitis. In contrast, Crohn’s Disease does not present with bloody stool.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of ulcerative colitis, alleviating factors

A

Crampy lower abdominal pain, relieved by bowel movement; Bloody stool; No mass; Confined to mucosa; Continuous from rectum (colon only); No granulomas;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

4 basic GI processes

A
  • Motility - muscular contractions that mix and move forward the contents of the GIT
  • Secretion - glands located along the GIT that secrete their contents into the tract, assisting in motility, digestion and absorption
  • Digestion - the biochemical breakdown of large particles and molecules into smaller, absorbable particles
  • Absorption - small particles are absorbed from the GIT into the blood or lymph
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 broad categories of movement (motility) in GI

A

1) Mixing movements: Redistribute luminal contents locally, enhancing the exposure to digestive secretions; expose luminal contents to GIT epithelium for absorption.

2) Propulsive movements: Move luminal contents forward. Rate of propulsion varies with specific function of region (e.g., esophagus = rapid; small intestine = slow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What layers make up the small intestine?

A
  • Muscularis externa is the major smooth muscle layer of the GIT. It has two layers:
      • Inner circular layer - responsible for restriction of the lumen
      • outer longitudinal layers - responsible for shortening of the GIT
  • Myenteric plexus lies underneath, coordinating muscularis externa contractions.
  • Inner most layer is the Muscularis Mucosae, which is a thin layer of smooth muscle between the mucosal and submucosal layers.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the role of Ca2+ and Myosin Light Chain Kinase in GI smooth muscle contraction

A
  • increased intracellular Ca2+ leads to binding of Ca2+ and calmodulin.
  • the Ca-Calmodulin complex activates Myosin Light Chain Kinase (MLCK)
  • MLCK phosphorylates myosin, which can now bind actin and perform shortening of muscle fibres.
  • Contraction is terminated when Myosin Light Chain Phosphatase cleaves phosphate from myosin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can a smooth muscle cell increase Ca2+ levels for contraction? (2)

A

1. Calcium-induced calcium release: Depolarisation of membrane brings Ca into cell via voltage gated calcium channels at base of calveoli (indentation at membrane). The influx of Ca induces sarcoplasmic reticulum to release of Ca .

2. Pharmaco-mechanical coupling: IP3 receptor in SR responds to elevated cytosolic levels of IP3 by releasing Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the role of the Interstitial Cells of Cajal (ICC) as ‘pacemaker’ cells for GI smooth muscle contraction

A

These are specialized smooth muscle cells of GIT that act as pacemakers for contraction! The undergo spontaneous, transient membrane depolarisations that are propagated to adjacent smooth muscle cells via gap junctions, resulting in SLOW WAVES. Greater # of APs sent along, increases the strength of contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are the duration and amplitude of slow waves modulated?

A

By enteric motor neurons in the walls of the GIT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

List the components of ENS

A

1) Sensory neurons (including mechanoreceptors, chemoreceptors and osmoreceptors)
2) Interneurons (excitatory and inhibitory)
3) Secretomotor cells, which influence… - Smooth muscle - Epithelial cells that secrete or absorb fluid/electrolytes - Enteric endocrine cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the role of the enteric NS in the regulation of GI motility

A

The enteric NS can operate entirely in the GI wall without external input (it’s reflexive). Moderate contraction by sending NTs to ICCs and smooth muscle cells in the circular and longitudinal muscle layers, which result in increased intracellular Ca levels and consequent contraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Autonomic Nervous System regulation of GI motility

A

En Passant Innervation: motor axons have multiple varicosities containing NT that can be released into smooth muscle to reach targets The ANS communicates with the ENS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the 3 phases of swallowing

A

1) ORAL PHASE: pushing food bolus toward the back of oral cavity and up against the palate. Requires tongue.
2) PHARYNGEAL PHASE: Touch and pressure receptors in the pharyngeal nerve (in pharynx) send stimulation to medulla via trigeminal nerve, thus initiating reflexive component of swallowing. Pharyngeal wall contracts, thus pushing food into esophagus. Tongue prevents bolus from travelling backward into mouth. Uvula elevates to seal nasal passages. Vocal cords contract and epiglottis closes over the trachea.
3) ESOPHAGEAL PHASE: swallowing centre relaxes pharyngeoesophageal sphincter and initiates primary peristaltic waves by interacting with ENS, to propagate the bolus toward the stomach. These are paired with secondary peristaltic waves, which are triggered by stretch and act to dislodge bolus. Gastroesophageal sphincter opens when a peristaltic wave pushes food bolus against it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What coordinates the motion of swallowing?

A

The swallowing centre in the medulla oblongata. The initiation of swallowing is voluntary, but once it starts, completion of swallowing in reflexive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the opening of the gastroesophageal sphincter

A

The vagus nerve mediates reflexive relaxation of the sphincter when a food bolus is pushed up against it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe primary peristalsis

A

~5-9 seconds of travel along esophagus

  • Inner circular layer of muscularis externa contracts, pinching a ring
  • Outer longitudinal muscle layer contracts in front of the inched ring, reducing the length of the tube
  • This sequence propagates along the length of the esophagus, pushing luminal contents toward the stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What initiates the reflexive phase of swallowing?

A

Pressure of food against the pharyngeal palate stimulate the trigeminal nerve which signals reflexive swallowing to occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the 2 major motility paradigms in the small intestine?

A
  1. segmentation 2. Migrating Mobility Complex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Explain segmentation

A

Dominant motility in small intestine right after a meal, responsible for mixing chyme and moving it toward large intestine. Composed of alternating contractions and relaxations of adjacent sections of the intestine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What initiates segmentation? (3)

A

distension of the lumen

presence of gastrin

parasympathetic input

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the migrating mobility complex?

A

Replaces segmentation following the absorption of a meal. Moves luminal contents along the intestine in periods between meals. Begins at the duodenal-gastric junction and consists of weak peristaltic movements that travel short distances. A second wave begins more distally than the previous to move contents along.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pathophysiology of achalasia

A

= functional disorder of the esophagus characterized by increased resting tone and incomplete relaxation of the lower esophageal sphincter, preventing food from entering the stomach.

can be recognized by the ‘bird beak sign’ on radiology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is esophagitis (2) and what may cause it (3)?

A

= inflammation and epithelial damage of esophagus

  • May be caused by reflux (GERD), infection of immunocompromised, eosinophilic esophagitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is GERD?

A

= gastric contents leak backward into the esophagus causing irritation/inflammation of esophagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Barrett's esophagus: what it is and how it may progress
= distal squamous mucosa of esophagus is replaced by metaplastic columnar epithelium. A response to prolonged injury, columnar epithelium may be more resistance to acid. ## Footnote Barrett's esophagus is a complication of GERD that may progress to esophageal adenocarcinoma. Premalignant dysplasia does not invade lamina propria. Graded based on histologic assessment.
26
Pathophysiology of diaphragmatic (hiatal) hernias types (2) possible presenting Sx (2)
= abnormal protrusion of a segment of the stomach above the diaphragm. Can be (a) sliding or (b) paraesophageal/nonaxial Usually asymptomatic, can have reflux or heartburn.
27
Gastritis: what is it? Acute vs chronic vs chornic active
= inflammation/irritation of the gastric mucosa ACUTE: sudden onset; often with erosions or ulcer. Often caused by NSAIDs, alcohol, cocaine, stress, trauma. CHRONIC: Ongoing. Often multifactorial and often combined with acute. Due to infection, autoimmunity, reactive. CHRONIC ACTIVE: persistent inflammation of the gastric mucosa related to **h pylori**. Typically affects antrum of stomach and may extend to body. Increased risk of gastric carcinoma and gastric lymphoma.
28
Peptic ulcer disease: define, possible complications
= acid-induced ulceration of the mucosa and wall of the stomach or duodenum often associated with h. pylori. Complications: perforation, hemorrahage, obstruction (stenosis), penetration
29
Carcinoma of the esophagus
didn't find this in lecture but it is an objective so check CBL research from the week.
30
Gastric Polyps
= abnormal growth of tissue projecting from a membrane in the stomach Can be neoplastic (benign or malignant) or non-neoplastic (hyperplastic or fundic gland polyp)
31
Gastric carcinoma (define, prevalence, appearance)
= malignant neoplasm of gastric epithelium - **adenocarcinoma** * Prevalence: more common in certain countries (i.e., Japan and less common in north america) * Appearance: intestinal-type epithelium with signet ring cells, ulcerating.
32
Eosinophilic esophagitis How does it present????
= a type of esophagitis characterized by numerous eosinophils within the squamous mucosa and associated with _dysphagia_ may present as difficulty swallowing, food impaction, heartburn Looks like rings in the trachea on endoscopy. Biopsy needed to confirm eosinophils. Must exclude GERD.
33
causes of GERD (5)
- low resting tone in lower esophageal sphincter - delayed esophageal clearance - delayed gastric emptying - increased abdominal pressure - increased acid production
34
Symptoms of GERD
Variable - heartburn, water brash, belching, retrosternal pain
35
How is GERD diagnosed? (2) when is endoscopy warranted?
Clinically - history and relief with medication (PPI) Endoscopy warranted if... * heartburn presents with alarm symptoms (bleeding, weight loss) * Persistent reflux or previous severe erosive esophagitis * History of esophageal stricture with persistent dysphagia
36
What are some complications that may occur with GERD?
- stricture (scarring) - ulceration - bleeding - barrett's esophagus - adenocarcinoma
37
What may be seen on biopsy of GERD?
- increased inflammatory cells in the epithelial layer (eosinophils, neutrophils, excess T lymphocytes) - basal cell hyperplasia - elongation of lamina propria
38
Treatment for GERD
- PPI to decrease acid production - Antacids - Diet modifications - Weight loss
39
Endoscopic and histologic features of Barrett's esophagus
Endoscopy: - red vevety GI type mucosa between pale squamous mucosa. Tongues extend upward from gastroesophageal junction or may be a broad band moving the who junction up. Histology: - squamous epithelium replaced by columnar epithelium or intestinal type and may see other types of glandular epithelium.
40
Treatment for Barrett's Esophagus
- anti-reflux therapy - endoscopy every 1-2 years to assess for dysplasia, carcinoma
41
Tests for h pylori
Serology urea breath test stool antigen test biopsy
42
Composition of gastric juice (3)
## Footnote - Water - Organic compounds (Intrinsic Factor, Pepsinogen, Lipase, Mucus) - Ions (Na+, K+, H+, Cl-, HCO3-)
43
Progression of Type 2 Diabetes (stages; 3) Insulin blood levels and appropriate treatment at each stage
Early * Abnormal oral glucose tolerance test (OGTT) but normal fasting glucose * Treat with diet and exercise Overt, but mild T2D * Moderate fasting hyperglycemia develops (~7 mM) * Treat with diet and exercise and add oral hypoglycemic agents (sulfonylureas), insulin-sensitizing drugs (metformin), DPP-4 inhibitors, and/or GLP-1 analogues. Advanced: * Severe fasting hyperglycemia (\>9 mM) * Insulin dependence often required
44
Possible causes of insulin resistance?
* Involves genetic and/or acquired defects in insulin action. Can arise as part of other syndromes (i.e., PCOS) or rare gene mutations. * Associated with obesity (especially central obesity)/BMI * Associated with inflammation in adopose tissue (macorphages produce TNFalpha)
45
Characteristics of insulin secretion in type 2 diabetes
* Impaired glucose-induced insulin secretion from B cells * Impaired proinsulin processing --\> manifests as hyperproinsulinemia * B cells become unable to compensate for increasing insulin resistance and produce decreasing amounts of insulin
46
Causes of decline in unsulin secretion in type 2 diabetes (3)
1. Glucose and lipid toxicity to beta cells 2. Increased # islet macrophages that make pro-inflammatory cytokines 3. Toxic amyloid deposits build up in pancreas
47
Monogenic forms of diabetes (2)
Mature onset diabetes of the young (MODY) Neonatal diabetes mellitus
48
MODY
Mature Onset Diabetes of the Young ~2-5% of all type 2 diabetes. All associated with renes that regulate B cell mass or function
49
Neonatal Diabetes Mellitus
Rare: born with type 2 diabetes; a single gene type Formerly diagnosed as type 1 diabetes, which influences the efficacy of treatment. Now treated with sulfonylureas
50
Gestational Diabetes Mellitus (progress, risk to infant)
Appears during pregnancy and disappears following birth. Pregnant women become insulin resistant and insulin secretion increases. \>50% of GDM women later develop T2D. Carries risk for the infant (increased size, dificult birth)
51
Reducing progression of type 2 diabetes
lifestyle modifications are very effective for slowing progression of diabetes. Metformin is also effective but not actually as much as lifestyle changes!
52
what do parietal cells produce and where are they located?
They are located in oxyntic glands of stomach body and they produce HCl and Intrinsic factor
53
What do chief cells produce?
pepsinogen (turned to pepsin by HCl) and lipase
54
What do ECL cells produce?
histamine
55
what do D cells produce?
somatostatin
56
what do G cells produce?
Gastrin
57
how is gastrin released and what does it do in the stomach?
Gastrin is released into the blood stream (endocrine) from G cells in the pyloric glands of the stomach. It acts on parietal cells to increase HCl secretion and on Chief Cells to increase pepsinogen secretion. It also increases contractions of the stomach.
58
Mechanism of acid production by parietal (oxyntic) cells
* Stimulation of the stomach stimulates the tubulovesicles to fuse with the canaliculi of parietal cells to form long microvilli * H+/K+ ATPase proton pump in tubulovesicle membranes is now on microvilli surface and facilitates production of HCl * The cell received CO2 from blood, which is is taken with water by Carbonic Anhydrase to make HCO3- + H+. * H+ from this reaction is exported out of the cell into the stomach by the **H+/K+ ATPase** * Cl moves from the blood, through the cell, and to the stomach down its concentration gradient, where it combines with H+ int he stomach to make HCl
59
Define the term 'zymogen' and describe the specific conversion of pepsinogen to pepsin.
Pepsinogen is produced by chief cells in the stomach. Pensinogen is cleaved by acid (HCl) to its active form (i.e., pepsinogen is a zymogen), pepsin. Pepsin can also activate more pepsinogen directly - this is called autocatalysis
60
What are the components of the gastric mucosal barrier?
Mucus (sticky secretions containing mucin and glycoproteins) and bicarbonate
61
Explain the significance of the gastric mucoasal barrier in mucosal protection
Protects the luminal epithelium from acid and pepsin-based hydrolysis as well as microorganisms.
62
Where is mucus produced in the stomach lining?
**Mucus neck cells** of gastric glands secrete clear mucus in response to several stimuli (e.g., mechanical/vagal stimulation, ACh, PGs, bacterial toxins) **Surface epithelial cells** continuously secrete viscous mucus with high [HCO3-] via exocytosis. Mucus is held in place by the surfacephosopholipids on the luminal membrane f the cells to lubricate and protect against damage.
63
Role of prostaglandins (PGs) in the stomach (5)
Involved in the protection of the stomach. * inhibit acid secretion * prevent exfoliation of epithelial cells * increase mucosal blood flow * stimulate mucus and bicarbonate secretion * enhance synthesis of surface-active phsopholipids that line the gastric mucosa and hold mucus in place.
64
Gastrin (where it comes from, what stimulates it, what it binds to, what it does)
Comes from G cells in the pyloric glands in the antrum of the stomach; Secreted in response to the peptide NT GRP (gastrin releasing peptide) from enteric neurons and in response to digested protein in the gastric lumen; Binds to CCK receptors on the basal surface of parietal cells and chief cells to activate them, thus upregulating their products.
65
Describe the roles played by gastrin, histamine, and ACh in the regulation of gastric secretion
HCl is produced by parietal cells, which have receptors for gastrin (CCK receptor), histamine (H2 receptor), and ACh (M3 receptor). Gastrin is released by G cells in the pyloric glands of the stomach in response to presence of digested protein or in reposnse to GRP released by enteric neurons. Histamine is released by ECL cells in response to gastrin and in response to ACh stimulation from neurons. ACh action on the parietal cells is the product of direct stimulation from neurons.
66
Explain how ACh, gastrin, and histamine stimulate the parietal cell in a coordinated fashion
There is thought to be continuous background release of histamine in gastric interstitial fluid to maintain basal acid secretion. Gastrin and ACh can act both via stimulation of histamine and synergistically with histamine direclty on the parietal cell.
67
What are the three phases gastric secretion
cephalic (psychic), gastric, and intestinal
68
Describe the stimuli and neural pathways involved in the cephalic phase of acid secretion (3) Explain inhibition of this pathway (1)
The cephalic phase is responsibel for preparing the stimach for an incoming meal. COnscious thought, smell, and taste stimulate the hypothalamus, which activates parasympathetic outflow from the vagus nerve. This stimulated chief cells and G cells to release acid and pepsin in the stimach before food even arrives in there. _Inhibition_: Stomach filling and feelings of satiety result in sympathetic discharge.
69
Describe the stimuli and neural pathways involved in the gastric phase of acid secretion (non-neuronal and neuronal aspects) Explain inhibition of this pathway.
Rate of secretion is maximal during the gastric phase. There are two components: ## Footnote _Non-neuronal_: Food entering the stomach increases pH, stimulating gastrin release and stimulating parietal cells directly. _Neuronal:_ Food entering the stomach causes distension, which activates a **vago-vagal reflex** via mechanoreceptors in the gastric wall. This results in stimulation of acid and pepsinogen release and indirect stimulation of gastrin release. _Inhibition_: pH drop in the antrum stimulated D cells in pyloric glands to release somatostatin, which acts locally to inhibit G cell production of gastrin.
70
Describe the stimuli and neural pathways involved in the intestinal phase of acid secretion Explain inhibition of this pathway
Nutrients (peptones) in the duodenum stimulate G cells to secrete more gastrin, which then acts on parietal cells and chief cells in gastric glands. _Inhibition_: Passage of chyme into duodenum and its breakdown inthe jejunum stimulates the **enterogastric reflex arc**, leading to production of enterogastrones. Enterogastrones feedback to inhibit G cell, parietal cell, and chief cell activity as well as smooth uscle contraction in the stomach.
71
Somatastatin. When it is released and what it does
Somatostatin is released from D cells in the pyloric glands in response to pH drop in the antrum. It acts to inhibit the gastric phase of acid secretion by locally inhibiting G cell production of meal-stimulated gastrin.
72
Enterogastrones - what are they - when are they produced - what do they do
Entrogastrones include secretin (stimulated my acid), SSK (stimulated by AAs and fat), GIP and GLP-1 peptides (stimulated by fat and glucose). They are all hormones produced as a response to chyme passage to duodenum ad jejunum. They act to inhibit the intestinal phase of acid secretion by feeding back to inhibit G cell, parietal cell, and chief cell activity as well as smooth muscle contraction in the stomach.
73
Why are NSAIDs hard on the stomach?
They inhibit the production of PGs. PGs' role int hes tomach is to inhibit acid secretion, increase mucosal flow/production, enhance synthesis of surphase phospholipids, and prevent exfoliation of epithelial cells. Inhibiting PGs inhibits this important protective mechanism for the gastric mucosa.
74
How does h pylori cause harm in the stomach? What characteristics of h pylori help it survive and do harm in the stomach?
* Mechanism of damage: Inject viruluence factors into epithelial cells, causing them to release nutrients and urea to nourish the bacteria. This damage the epithelial cells and their tight junctions, resulting in inflammation. Cytokines related to inflammation stimulate G cells (++gastrin) and inhibit D cells (--somatostatin), increasing acididty and furthering injury. * Adapted to survive in the stomach: Flagellated and motile with chemotaxis toward high pH areas of stomach (mucus). Adhesive to epithelial cells. Produces a potent urease, which converts NH3 and CO2 to protect itself from gastric acid and promote further gastrin secretion.
75
General treatment for h pylori infection in stomach
Standard triple therapyy combined PPI and 2 antibiotics (clarithromycin and amoxicillin or metronidazole)
76
Peppermint - effect on GI?
worsens heart burn
77
caffeine - effect on GI disease
worsens heartburn
78
How does heartburn present? symptoms aggravating factors and alleviating factors
post-prandial, retrosternal pain of varying duration and severity. May experience water brash, sour taste, odynophagia (pain with swallowing) aggravating - supin position, caffeine and peppermint (foods that relax upper esophageal sphincter), fat and protein (foods that delay emptying) alleviating - antacids
79
Things that may cause heartburn (5)
peppermint, caffeine, opioids, smoking, alcohol
80
Define GERD
gastroesophageal reflux disease. Retrograde movement of gastric contents into the esophagus with symptoms AND/OR complications.
81
reflux esophagitis
Acid damage to esophagus. A common complication of GERD. Caused by increased abdominal pressure, increased volume in stomach, or decreased esophageal clearance.
82
Treatment for reflux esophagitis (lifestyle, medications, surgery)
1. Correct underlying cause 2. Lifestyle changes (remove exacerbating factors such as smoking, alcohol, weight) 1. Medications: antacids, H2 antagonist (OTC), PPI (slower onset but more effective). Usually stopped after symptoms resolve and relief maintained with lifestyle modification. 3. Surgery: Fundoplication - wrapping stop of stomach around the esophagus (rarely performed)
83
Possible complications of esophagitis (3)
Pain/bleeding Stricture Barrett's esophagus (progresses to adenocarcinoma)
84
Possible causes of esophagitis and their different manifestations (4)
* _Infection_ (HSV, CMV, candida): typically in immunosuppressed and v painful (odynophagia) * _Inflammatory (eosinophilic)_: rings form in trachea, exudate produced; can be treated with elimination diet * _Trauma (pill):_ causes painful swallowing, common in elderly (impaired esophageal clearance) * Reflux
85
Dyspepsia - formal definition
"stomach ache" **Rome III definition =** one or more of... * post-prandial fullness * epigastric pain or burning * early satiety Sometimes associated with nausea, bloating, anorexia
86
Causes of dyspepsia
* Usually no obvious cause: ulcer-like symptoms or dysmotility-like symptoms
87
Gastritis vs gastropathy
Gastritis = inflammation of gastric mucosa associated with injury (h pyloria, autoimmune, alcohol) Gastropathy = epithelial cell damage and regeneration _without inflammation_ (NSAIDs, bile reflux, congestion)
88
causes of acute vs chronic gastritis
Acute (alcohol, early h pylori) Chronic (autoimmune, late h ylori)
89
Different physical patterns of gastritis
**Antral-based gastritis** - infection increases gastrin secretion, which increases parietal cell acid production, causing duodenal damage. May eventually cause metaplasia in stomach or duodenum or produce ulcers in stomach or duodenum. **Corpus-predominant atrophic gastritis or pangastritis** - caused by genetically lower acid output, predisposing the body for h pylori infection. Increased risk for ulcers, metaplasia, and gastric CA.
90
Purpose of a urea breath test
test for h pylori by investigating the presence of urease enzyme which braeks down uria into ammonia and carbon diaoxis. Pt swallows radiolabelled urea and radiolabelled CO2 is measured in breath. Diagnostic for dyspepsia.
91
Peptic ulcer disease = ?
damage to the mucosal lining of the intestinal surface where acid is implicated in pathogenesis. May vary from normal mucosal to erosive (damage restricted to superficial mucosa) to ulcerative (damage extends to muscularis mucosa).
92
Management of peptic ulcer disease
* correct underlying cause * Lifestyle changes * Medication: PPI * Endoscopic: injection around ulcers to stop blood leak coagulation of vessels if ulcer is shallow, place clips to hold ulcer shut, embolizaation (obstruct problem blood vessel), omental patch, other surgical approaches.
93
Dysphagia
= dysfunctional swallowing. May be progressive (i.e., cancer) or longstanding (physical difference)
94
How to approach a diagnosis for dyphagia
Where is the issue? transfer (oropharyngeal vs esophageal) What is the issue? SCC \> adenomacarcinoma \> pepstic stricture
95
Pro and con of an abdominal XR for diagnosis of GI diseases
Easy to get, cheap Won't show mild inflammatory bowel disease
96
Pros and cons of doing a barium swallow
Easy and cheap Low sensitivity and specificity Good for testing dysphagia
97
Pros and cons of doing a CT abdomen
3D information, very sensitive and specific. Expensive Exposure to ionizing radiation Best test for severe abdominal pain
98
CT enterography: what is it and pros/cons
Same as a CT abdomen, but with negative PO contrast and another IV contrast. ## Footnote Good for showing strictures, intraluminal fillinf defects. Better than plain CT if you are suspecting Crohn's disease
99
MR pelvis, abdomenen / MR Enterography / mRCP What are these and why do it?
Similar to a CT but non-ionizing. Not affected by bones so it can image with high resolution close to bony structures. All are better resolution than CT. MR enterography is analogous to CT enterography with contrast added. MRCP is magnetic resonance cholangiopanreatoagraphy - excellent for viewing liver, biliary tree, and pancreas. Best first test in pelvis and pt \< 25 years old.
100
Endoscopy pros and cons
* Most sensitive and specific test for intraluminal lesions, BUT not able to detect lesions outside of the lumen * Able to diagnose, take biopsies, and perform interventions all during the same procedure, BUT it's invasive and ofter requires sedation
101
Endoscopic ultrasound
Can be done in upper or lower GIT, producing highly detailed images of internal organs. Can take biopsies and perform injections during the procedure.
102
Esophageal manometry - what is it and pros/cons
Patient swallows to map out pressure points (i.e., achalsia stricture). Detects abnormalities earlier in disease process than imaging (more sensitive). Accurate for distinguishing between mobility disorders or esophagus (fairly specific). BUT Invasive and very expensive, plus need a specialized lab and person to perform the investigation
103
ddx for odynophagia
Ingestion - pills, food (stuck) Infection - CMV, HSV (candida dysphagia \> odynopagia) Inflammation - radiation, Crohn disease
104
Define colitis and proctitis
Inflammation and epithelial damage of colon (colitis) and/or rectum (proctitis) mucosa
105
possible causes of colitis or proctitis (3)
infection, inflammatory bowel disease, ischemic colitis, or other
106
What is inflammatory diarrhea?
Diarrhea containing red cells and white cells and debris. Requires microscopic evaluation and usually associated with inflammation of the colorectum.
107
Inflammatory Bowel Disease
Two seperate diseases (Crohn Disease and Ulcerative Colitis) of uncertain etiology characterized by inflammation in the GIT. May be 'indeterminant type' IBD, which means unable to differentiate between UC & CD. Etiology is poorly understood - genetic and environmental factors.
108
Physical and histological characteristics of Crohn Disease
* Any part of GIT ('gum to bum') * Patchy distribution * Transmural inflammation with associated serositis * Granulomas * - Cobblestone appearance of mucosal surface due to linear ulceration * - Thickened walls, narrowed lumen * - Abscess * Radiology: string sign
109
What is pictured here? What may it suggest
Granuloma of the colon, may be Crohn Disease
110
What diagnosis is supported by this radiograph?
Crohn Disease
111
Physical and histological characteristics of ulcerative colitis
* - Colon only (starts in rectum) * Continuous involvement * - Inflammation limited to mucosa * No granulomas * - Affects mucosal layer only * - Absence of goblet cells * Crypt distortions and abscesses
112
Possible complications of Crohn Disease
- Fistula tracts - Stenosis and obstruction - Dysplasia and carcinoma - Extraintestinal features (arthritis, eye lesions, skin lesions)
113
Possible complications of ulcerative colitis (3)
- Toxic megacolon (rare today) - Dysplasia and carcinoma - Extraintestinal features (arthritis, eye lesions, skin lesions)
114
Microscopic colitis - how does it present
Presents with chronic, water, non-bloody diarrhea. Colonoscopy is normal but mucosal biopsy is abnormal.
115
Diverticular disease Define Risk factors Possible complications
= multiple diverticula, usually on the left side of the colon that may be associated with normal function. Risk factors include lifestyle (low fibre diet, inactivity, obesity) and muscle weakness. Caused by high intraluminal pressure. Complications: Diverticulitis (infalmmation of a diverticulum - could leed to abscess), bleeding, associated colitis
116
Describe the two kinds of polyps that can occur in the colon or rectum
Polyps are abnormal tissue growth projecting from a mucous membrane. **Sessile polyp** has a broad base **Pedunculated polyp** has a stalk Polyps can be neoplastic (premalignant, malignant) or non-neoplastic
117
What is colorectal adenoma
epithelial neoplasma that have potential to progrss to carcinoma. Should be considered a premalignant neoplasm.
118
Describe the different ways a colorectal adenoma may appear on histological examination
Tubular, villous, or tubulovillous
119
Define colorectal carcinoma
Malignant epithelial neoplasm of the colorectum that has invaded through the muscularis mucosae. One of the most common malignant neoplasma and a leading cause of cancer death in mean and women.
120
Risk factors for colorectal cancer (2)
Genetics (FAP, Lynch) and environmental (diet)
121
Progression of colorectal adenocarcinoma
The vast majority are adenocarcinomas, often preceded by non-invasive pre-malignant adenomas (a type of colon polyp). Staging by TNM * Tumor size/depth/invasion through submucosa * Lymph Node spread * Metastasis to distant sites Grading by appearance and histological differentiation/rate of growth/division.
122
Appendicitis
Acute inflammation of the appendix usually secondary to obstruction of appendiceal lumen. obstruction of lumen --\> bacterial overgrowth --\> inflammation --\> increased pressure --\> local ischemia --\> perforation --\> peritonitis or abscess
123
Neoplasms of the appendix
Neuroendocrine (carcinoid) tumour is the most common neoplasm of the appendix. A carcinoid tumour is a neuroendocrine tumour that produces serotonin. Typically benign, but can metastasize. **Carcinoid syndrome:** symptoms such as flushing, diarrhea, and wheezing may occur if the tumour metastasizes to the liver or serotonin is released into systemic circulation.
124
What are the major macronutrients?
The major components of the diet - sugars, proteins, and lipids. Often in polymer forms that must be broken down before they may be absorbed. The daily requirement for protein is fixed, but carb and lipid amounts may vary. Proteins: 9 of 20 AAs must be obtained from diet (i.e., are essential) Fats: 2 FAs are essential (linoleate and linolenate)
125
What are the major micronutrients? Their role? General absorption.
Micronutrients are the minor components of diet that are functionally critical. They include **vitamins** (fat and water soluble) and **minerals**. Water-soluble vitamins are essential because they are co-factors for enzyme function. Functions of fat-soluble vitamins vary. Some micronutrients may be absorbed directly, but some must be modified before they may be absorbed (i.e., B12, folate, iron).
126
Describe the structural components of the intestinal mucosa responsible for regulating intestinal transport
* Small intestine lined by _simple columnar (absorptive) epithelium_. Little EC matrix bt cells, cells linked by cell-cell junctions. Cells form epical villi.
127
What are the barriers to free movement of digested nutrients across the mucosal epithelium of the intestines? Where is paracellular transport possible?
The enterocytes of the simple columnar epithelium of the intestinal mucosa are bound together by apical tight junctions and their microvilli have a glycocalyx brush border. Tight junctions present 'transepithelial resistance' that is lower is the small intestine, where small, charged ions can move down the conc grad through tight junctions between cells - **paracellular transport.** Beyond the enterocytes themselves, there is a basolateral plasma membrane, and a basement membrane before contacting the blood or lypmhatic capillary.
128
Differentiate paracelluar and transcellular transport in the intestine.
Apical tight junctions between enterocytes present 'transepithelial resistance' that is lower is the small intestine, where small, charged ions can move down the conc grad through tight junctions between cells - **paracellular transport**. On the contrary, **transcellular transport** is transport across the plasma membrane of enterocytes. Material moves through cells by diffusion, facitiated transport, active transport, or micropinocytosis/endocytosis.
129
Explain differing levels of macronutrient absorption in different places in small intestine
most carbs and proteins are absorbed in the first 50% of small intestine (duodenum and jejunum) and lipids (as well as lipid soluble vitamins) are delayed because they take longer to digest.
130
Describe the process of fat digestion and absorption in general terms
Fat breakdown is initiated in the stomach (gastric hydrolysis) where fats start otbe dispersed and emulsified. Further fat hydrolyces and micelle formation takes place in the small intestine. After complete digestion/breakdown of fates, absorption is normally 98% efficient. SOme complex fats (i.e., TGs, and phospholipids) are resynthesized within enterocytes. Absorbed fats may then be packaged into chylomicrons and taken away in the lymph. Fats packaged as glycerol and some free FAs will also be taken up into portal blood.
131
Gastric lipase
Contributes to early dispersion of large fats, with preference for breaking the third Fa off of a TG. Efficient at low pH.
132
emulsification
The release of free FAs, mixing and interaction with protein breakdown products, resultin gin disperion of large fat globules into small lipid droplets in the chyme.
133
Role of pancreatic lipases
Generate lipids with polar head groups that faciltiate further emulsification. Colipase helps anchor lipase to emulsification droplets once they are coated with bile salts. Very small droplets mean large SA to volume ratio
134
Role of bile salts in digestion
Form a shell around FAs and monoglycerides - a micelle - in partnership with other lipid breakdown molecules (lipase and colipase). Micelles may then move through the aqueous 'unstirred water layer' to reach the apical'luminal surface of enterocytes.
135
Lipid absorption into enterocytes
_Absorption of short/medium length FAs_ occurs primarily via (a) directly partitioning into microvillus membrane. But also occurs via (b) carrier mediate, facilitated diffusion with protein transporters. Does not require solubilization of the micelle as most of these lipids are on the micelle surface. _Absorption of long chain FAs, monoglycerides and cholesterol_ usually requires dissociation/breakdown of the micelle as these less soluble lipids are often buried inside. Most require binding proteins in the microvillar membranes of the enterocytes.
136
Transport of lipids to blood
Small and medium chain FAs are released baslaterally and diffuse into capillaries that drain into the hepatic portal vein (--\> liver). Long chain FAs and monoglycerides are re-esterified with glycerol to form TGs int he enterocyte. **TGs, cholesterol, phospholipids, fat soluble vitamines are packaged by apolipoproteins in the Golgi and secreted by exocytosis as chylomicrons basolaterally.** Chylomicrons are exocytosed, pass through basement membrane and enter the **central lacteals** (discontinuous with lymphatic capillaries). They bypass th eliver and enter the bloodstream at the thoracic duct. They can then be broken down in the blood by lipoprotein lipase to free FAs, glycerol and cholesterol. Cholesterol may then travel to the liver to be incoporated into LDL. Intestinal cells can also produce and secrete cholesterol-rich, VLDL, which can pass into the blood. VLDL is a prominent route of cholesterol management when fasting.
137
4 major types of dietary carbohydrates
1. starch - long chains of sugars (digestible) 2. dietary fibre - long chains of sugars (non-digestible) 3. Dietary disaccharaides (digestible) 4. dietary monosaccharaides (fully digested)
138
amylose vs amylopectin
alpha amylose has alpha 1:4 bonds amylopectin has alpha 1:4 bonds and alpha 1:6 bonds
139
Describe how carbohydrates are digested and absorbed across the intestinal wall
* amylase hydrolyzes 1:4 and 1:6 linkages, thereby initiating the breakdown of both linear and branched starch molecules. Amylase is broken down by gastric acid and then pancreatic amylase completes initial carb digestion in the duodenum. * Pancreatic amylase digestion generates di- and trisaccharaides * Enzymes in duodenal and jejunal brush border membrane fully break down dugars to monosaccharaides (galactose, glucose, fuctose) * Monosaccharaide transporters in the apical microcvillar membranes bring sugars into enterocytes and another group of tranpsorters expels them basolaterally into the interstitial fluid. SGLT1 brings in glucose/galactose paired with Na+ (Na+ expelled by Na/K ATPase to maintain gradient) and GLUT5 brings in fructose. Glucose, galactose, and fructose all expelled basolaterally by GLUT2 into the interstitial fluid where they may be transported into the blood.
140
Describe how proteins are digested and AAs, peptides, and polypeptides are absorbed across the intestinal wall stomach (1) duodenum (2) absorption of small ones (2) absorption of big ones (1)
* Stomach: Protein digestion is initiated in the stomach. Pepsinogen is cleaved to pepsin by HCl and then pepsin can perform autocatalysis on pepsinogen to further increase pepsin levels. * Duodenum: Pancreatic trypsinogen is cleaved to trypsin by enterokinase from enterocyte brush borders in the duodenum. Activated trypsin activates other pancreatic proteases and some lipases in the duodenum, which free up AAs, di- and tripeptides, and some slightly longer polypeptides. * AAs, di- and tripeptides brought across enterocytes by **direct transport** via the **peptide transporter** or **amino acid transporter**, which uses cotransport with a H+. The The H+ gradient is maintained by the **Na+/H+ exchanger.** transporters and released into the interstitial fluid for uptake into blood. * Longer polypeptides can be further hydrolyzed by brush border hydrolases. After uptake some peptides can be further hydrolyzed inta AAs intercellularly.
141
GALT
Gut-associated lymphoid tissue is important for immunity in the gut. Microfold (M)-cells are responsible for uptake of intact protein antigens.
142
absorption of fat soluble vitamins.
Most often absorbed passibled from icelles and transported out of the cells into chylomicrons as part of the lipid transport process
143
Absorption of water soluble vitamines
Water soluble vitamins are transported across the intestinal epithelium by a number of mechanisms, including facilitated diffusion, active transport, endocytosis (B12/coalbumin), and deconjugation followed by faciltiated diffusion (folate)
144
Absorption of minerals
Minerals are transported across the intestinal epithelium by a number of mechanisms, including active transport (Mg), facilitated diffusion (Ca), and alternate transport mechanisms based on the form of the mineral (Fe)
145
Where are bile salts/acids and coalbumin absorbed?
distal small intestine (ileum)
146
Explain absorptioin of cobalumin
* coalbamin = VitB12 * COBALAMIN (CBL) is ingest bound to proteins in food. Gastric acid and pepsin release it during protein digestion. * CBL is acid sensitive, so it binds to glycoprotein **haptocorrin,** which is produced by salivary and gastric glands and acts to protect CBL. * Pancreatic proteases digest haptacorrin in the duodenum, liberating CBL * **Intrinsic Factor** is secreted by parietal cells in gastric glands. Intrinsic factor complexes with CBL in the jejunum where pH is more neutral. * The CBL/IF complex binds a receptor on the apical membrane of ileal enterocytes (free CBL will not bind), which triggers receptor-mediated endocytosis. * CBL is liberated in the lysosome, then it complexes with **transcoalbamin II** and the complex is secrete basolaterally, where it may enter the intestinal capillaries. It will be delivered to the liver by the portal venous system
147
Calcium absorption
* Calcium undergoes passive absorption both paracellularly and transcelluarly in the jejunum and ileum * Transcellular transport begins in duodenum. Ca diffuses down concentration gradient through the apical brush border via **Ca Channels** * **Calbindin** is a protein syntehsized in response to the transcriptional activation of **Vitamin D**. Calbindin complexes with Ca to buffer levels of free Ca in the cytoplasm. * Finally, Ca is actively transported against its concentration gradient acorss the basolateral membrane of duodenal enterocytes.
148
Name the fat soluble vitamins
KADE these are transported in micelles passively
149
Two enterocyte pathways for ion absorption
**Paracellular** - between cells, down gradient through tirght junctions. Tight junctions most receptive in small intestine. Resistance increases as you move down the large intestine. **Trancellular** - crossing the membranes. Genearlly, at least one membrane passage is active, in order to push agains the gradient.
150
Na absorption in intestine
Paracellular in early small intestine and transcellular for whole intestine (large and small). In the proximal small intestine, Na enters enterocytes via Glucose/Na cotransporter (SGLT1) and AA/Na cotransporter. Na leaves enterocyte by Na/K ATPase. This process is not cAMP sensitive so it isn't affected by bost enterotoxins that cause diarrhea. Na can also enter via Na/H exchangers (NHE3) in response to high pH in the lumen. In the ileum and proximal colon, Na enteres enterocytes via Na/H exchanger (NHE3) just like before, but now it's coupled with a Cl/HCO3- exchanger, therefore the process is electrocially neutral. This process is inhibited by a number of signallying cascade and therefore may be a cause of diarrhea. In the distal colon and rectum, Na enters enterocytes via facilitated diffusion through **ENaC**, coupled to the Na/K ATPase, which maintains the concentration gradient. ENaC transport is upregulated by aldosterone (increases channel opening, channel transportation, channel synthesis, and Na/K ATPase synthesis)
151
How much fluid is absorbed in different parts of the intestine?
7. 5 - 12 L in duodenum and jejunum 1. 3-4.6 L in ileum and colon
152
What are the different roles of intestinal cells in crypts and villi surface in terms of transport in the intestine?
Crypts responsible for secretion and surface responsible for absorption
153
Cl absorption in the intestine
(a) Passive, voltage-gates Cl absorption (following the movement of Na+) occurs in both the small and large intestine (transcellular). (b) It can also occur paracellularly. (c) Electroneutral exchange of Cl- and HCO3- in the ileum and colon (can occur in both the presence or absence of parallel Na/H exchange). Driven by movement of Na and a charge gradient heightened by negatively charged AAs and carbs in the lumen. This modality can be disrupted by signalling cascades and lead to diarrhea.
154
Water absorption in the intestine
Water follows movement of Na and Cl. It is absorbed passively, driven by the osmotic gradient. It can be absorbed paracellularly (tight junctions) or transcellularly (directly, or via aquaporins or SGLT1). Assistance from aquaporins or co-transporters increases efficiency significantly. For every 1 glucose moved through SGLT1, 2 Na and 260 H20 go across, so this is the most efficient mode of H20 transport (responsible for 5 L absorption/day).
155
4 functions of intestinal fluid secretion
1) propel substances out of the crypts 2) maintain the fluidity of intraluminal contents 3) maintain osmotic equilibrium 4) dilute potentially injurious substances
156
Modes of fluid secretion in intestine
* Duodenum * _Crypt enterocytes_ secrete HCO3 rich fluid, related to the HCO3/Cl exchange at apical membrane * _Glands_ secrete mucinous fluid (contains lysozyme, Igs) by secretory exocytosis at slow rate that increases after feeding. * Jejunum and Ileum * _Crypt enterocytes_ secrete isotonic NaCl solution, driven in part by active secretion of Cl through CFTR channel. Na follows paracellularly down the gradient and water follows them both. CFTR channels are upregulated in response to Ca2+, cAMP, cGMP, which are all hormone regulated.
157
Factors influencing intestinal water and electrolyte transport (5)
1) hormones and paracrines produced by mucosal cells in response to luminal stimuli 2) NTs produced by enteric neurons 3) chemicals released by immune cells and fibroblasts in lamina propria 4) changes in capillary blood and lymphatic flow 5) smooth muscle contraction
158
What are the two major pathophysiological mechanisms for diarrhea?
1) decreased absorption of fluid and electrolytes 2) increased secretion of fluid and electrolytes
159
What mechanisms may result in decreased fluid and electrolyte absorption, ultimately causing diarrhea? (3) provide an example of each (3)
1. Inhibited ion transport (ex: e coli's enterotoxin inhibits NaCl absorption) 2. Increased osmotic pressure in lumen prohibits absorption of water (osmolar gap) (ex: production of short chain FAs and hydrogen in lactase deficiency results in diarrhea with acid pH) 3. Increased propulsive activity resulting in decreased contact time for absorption (ex: irritable bowel syndrome)
160
What mechanisms may cause increased secretion of fluid and electrolytes, ultimately leading to diarrhea? Give an example for each (2)
1. Stimulated anion secretion (ex: cholera bacterial toxins) 2. Secretion from hyperplastic crypts (ex: chronic inflammation characteristic of celiac sprue)
161
Explain the mechanism of diarrhea associated with celiac
* Gluten triggers an inflammatory response * Decreased brush border hydrolases results in unabsorbed osmoles * Villus atrophy (fluid, nutrient, and electrolyte malabsorption) * Crypt hyperplasia (increased endogenous secretion) * Inflammatory cells --\> inflammation-induced hyper-secretion by crypt enterocytes * * ULTIMATE RESULT: diarrhea
162
Cholera: Transmission, mechanism of diarrhea, treatment
* Cholera lives in feces and is contracted by contaminated food/water - cocurs in places lacking proper sanitation/clean water * Stream of events leading to elevation of cAMP, which inhibits neutral NaCl absorption and stimulates Cl- secretion. BUT nutrient-coupled Na absorption is not affected. * Treat by taking advantage of the fact that Na-nutrient uptake isn't affected. Administer Na/glucose solutions to replenish Na and minimize dehydration.
163
Differentiate between malabsorption and maldigestion
Maldigestion - defective hydrolysis of nutrients Malabsorption - defective mucosal absorption
164
Iron absorption
In orer for iron to be absorbed, it has to be in the Fe2+ state. Most ingested iron is Fe3+ or Fe4+ and requires interaction with acid to facilitate its absorption --\> so take it with orange juice.
165
How may the GIT adapt for absorption?
* Colon may adapt to better absorb certain nutrients * Villi can elongate and in crease in number (i.e., in small bowel resection) * Increased pancreatic enzyme production *
166
Anthropometry
Crude assessment of weight and body type to assess malnutrition. Includes BMI (kg/m2), weight, weight, hip/waist ratio, skinfold (fat), and general muscle bulk
167
Screening tools for nutritive state
**Subjective global assessment** : includes a physical exam (subcutaneous fat, edema, muscle bulk). Identifies pts who are malnourished. **Mini-nutritional assessment:** more often used in elderly patients; includes food intake, weight loss, mobility, psycholgical, BMI or SC fat
168
Define well nourished, mild/moderate malnutrition, and severe malnutrition
Well nourished = eating well and gaining weight; may still have weight loss and muscle wasting mild/moderate malnutrition = 5-10% weight loss, compromised food intake, continued weight loss, progressive functional impairment, moderate physiological stress severe malnutrition = \>10% weight loss, poor nutrient intake, progressive functional impairement, muscle wasting.
169
Function of a hydrogen breath test to assess for malnutrition
Assesses carb absorption. Administer a carbohydrate (i.e., lactose) and test breath at baseline and 2 h later. Diagnose lactose intolerance.
170
Schilling test
identify B12 deficiency/malabsorption. 1. Give a small dose radiolabelled B12 --\> absorbed by small intestine 2. Give large dose IM non-labelled B12 --\> saturate B12 carriers 3. Measure radiolabelled B12 in urine; malabsorption if \<7-10% of oral dose is recovered 4. Confirm site of malabsorption by administering intrinsic factor, then pancreatic enzyme, then antibiotic and see if the issue resolves. (antibiotic to see if SIBO is consuming gut B12)
171
Purpose of adminsitering a quantitative fecal fat test
Identify pancreatic insufficiency
172
Tests for pancreatic insufficiency (not blood work)
Quantitative fecal fat, fecal elastase/chymotrypsin
173
Presentations of Celiac
* **Classic**: abnormal histology, IgA EMA or tTG Ig positive | symptoms * **Atypical:** abnormal histology, IgA EMA or tTG Ig positive | normal and extraintestinal symptoms * **Silent:** abnormal histology, IgA EMA or tTG Ig positive | asymptomatic * **Latent**: Genetic susceptibility HLA-DQ2 or -DQ8 | lack of histological changes but current symptoms or will develop symptoms * **Refractory**: Symptomatic, severe histology, does not respond to gluten free diet for at least 6 mo
174
Pathophysiology of Celiac
Gluten/gliaden exposure triggers an inflammatory response • Villus atrophy (fluid, nutrient, and electrolyte malabsorption) • Crypt hyperplasia (increased endogenous secretion) • Enterocyte disarray • Inflammatory infiltrates --\> inflammation-induced hyper-secretion by crypt enterocytes • Decreased brush border hydrolases results in unabsorbed osmoles Results in: increased osmotic load, luminal electrolytes, FA production by colon bacteria, decreased release of bile acids and pancreatic enzymes in response to meals, unabsorbed bile salts in colon  DIARRHEA
175
Diagnosing Celiac
Serology: Anti-tTG IgA\*\*\*\*\*; OR Anti-Endomysial Ig; OR Anti-gliadin IgA, IgG Endoscopy & small bowel biopsy: marbelizatin of duodenum
176
4 histological findings for celiac
villus atrophy, crypt hyperplasia, enterocyte disarray, inflammatory infiltrates
177
Genes associated with development of celiac
HLA DQ2 or HLA DQ8
178
Mechanism of gluten sensitivity in celiac
Autoimmune response. Gliaden is taken into interstitium by an Ig, recognized by tTG, and presented on APCs via HLA DQ2 or HLA DQ8 (upregulated in celiac) to T cells. T cells mediate inflammation and B cells to make anti-gliaden and anti-tTG antibodies. Killer T cells come over and destroy enterocytes affected by inflammation. Summary: exposure results in **inflammation**, **heightened sensitivity (new Igs)**, and tissue destruction
179
a) acute appendicitis b) Ulcerative colitis c) Behcet's disease d) gastroenteritis e) Crohn disease
crohn
180
How to diagnose IBS
Rome IV Criteria: recurrent abdominal pain at least 1 day/week in the last 3 months associated with 2 or more of: - related to defecation - onset associated with a change in stool frequency - onset associated with a change in form (appearance) of stool
181
Red flags pointing away from IBS
* Weight loss * Onset after 50y * Family history of colorectal cancer or celiac disease * Joint pain, skin rashes * Malnourishment * Presence of a mass, obstruction * FOBT +ve (fecal blood) * Abnormal CBC, CRP, thyroid, electrolytes
182
Differentiate between chrohn and UC based on involvement of mucosa
Crohn involves the whole mucosal layer - big deep ulcers. Ulcerative colitis only involves the superficial mucosa.
183
Extrainstestinal manifestations of inflammatory bowel diseases
- eyes: uveitis (more in UC) - mouth: aphthous stomatitis (more in UC) - shins: e nodosum [rash] - ankles: pyoderma [ulcer-appearing] - feet - bones: arthritis (more in UC)
184
Classification of ulcerative colitis
Montreal classification considers the E(xtent) and S(everity) of disease.
185
How to assess risk in Crohn disease?
Number and extent of lesions and inflammation viewed in monitoring endoscopy informs how aggressive treatment needs to be.
186
Explain the therapeutic pyramid for active crohn disease
1. _Mild Disease_: topical treatment * Budenoside and aminosalicylates to bring down inflammation 2. _Moderate Disease_: * Biologics: infliximab * Systemic corticosteroids * Oral steroids * Azathioprine/6-MP or methotrexate 3. _Severe Disease_: * Surgery * Biologics: infliximab * Azathioprine/6-MP or methotrexate
187
5- aminosalicylic acid (5-ASA)
Often the first pharm therapy used in crohn disease. An antiinflammatory. Good to use this instead of using corticosteroids. Available in multiple forms (pH dependent, timed release, bacterial cleavage).
188
Using corticosteroids in treatment of crohn disease
Less than 50% of patients with CD require corticosteroid therapy. Reserve for more complicated disease courses. These drugs are effective at obtaining remission, but they have significant side effects (i.e., adrenal insufficiency, osteoporosis, more). Budenoside - a topically-acting steroid - has incrased the options for steriod use though. Can use corticosteroid to achieve remission and then maintain remission using Azathioprine.
189
Role of azathioprine in the management of Crohn disease
Azathioprine can be used to maintain remission in CD patients who achieved remission using corticosteroids and need to be tapered off.
190
Biologic options for treating crohn disease
Anti-TNFs have proven effective at healing the gut. Infliximab. May cause some immunogenic-related side effects. Use in tandem with an immunosuppressant.
191
When would surgery be appropriate in Crohn disease
Surgery for relief of symptoms or complications of the disease. IT's an effective treatment option when medical therapy has failed or complications arise. It should be considered very carefully.
192
Treatment options for ulcerative colitis based on severity of disease
Start with topical --\> oral --\> steroids --\> immunosuppressants --\> biologic
193
Indications for surgery in ulcerative colitis
Failure of medical therapy, cancer risk, perforation, hemorrhage, stricture
194
Surgery options for ulcerative colitis
formation of a J pouch? more?
195
Risk of cancer in ulcerative colitis?
upt o 20% risk after 30 years of disease. _Risk factors_: Duration of disease, extent of disease, presence of primary sclerosing cholangitis, FHx, dysplasia, endoscopic appearance, severity of inflammation
196
Causes of lower GI bleeding
C-HAND Colitis (infectious, inflammatory, ischemic) Hemorrhoids Angiodysplasia Neoplastic Diverticulsis
197
Dentate line
separates the rectal columnar epithelium from the anal squamous epithelium
198
Overview of hemorrhoids/fissures
Most common cause of GI bleeding in patients under 50. Usually minor and painless with hemorrhoids, but may be painful with fissures (little cuts). Pts present with fresh blood, often dripping into the toilet or streaked on their stool. Diagnosis by history, digital rectal exam, endoscopy.
199
Management for hemorrhoids/fissures
Lifestyle: high fibre, fluid, don't strain on toilet Medications: hydrocortisone ointments, sitz bath, fissues can be treated with nitroglycerin or other mode of dilating anal canal so it can heal Surgery: rarely indicated; banding, removal, injection of botox into sphincter or sphincterotomy for fissures
200
Diverticulosis. More common in what location and in what groups of people?
= sac-like protrustions from colon wall. Common with older age; associated with western diet. Mostly in sigmoid colon, however R sided in Asian pts.
201
Character of bleeding in diverticulosis
Usually large volume, painless. Usually stops spontaneously, but recurrent bleeds are common.
202
Diverticulitis (definition, presentation). Blood?
Infection of diverticulosis. Presents with pain, fevers, high WBC, **not typically bleeding.**
203
Management of diverticulosis (4)
* _Resuscitation_: ABCs * _Colonoscopy_: can be challenging; requires clean bowel and active bleeding * _Angiography_: contrast injected into a major artery to find the vessel that is bleeding. Use CT scan. Only detects bleeding at rates \>0.5mL/min. Can embolize (cauterize) the bleed once it is identified. * _Surgery_: Segmental resection may be warranted if bleeding is persistent. recurrent (3+ episodes annually), or pt is unstable despite recussitation.
204
Treating diverticulosis bleed
Inject with epinephrine
205
Ischemic colitis: Definition & Presentation & Diagnosis
Reduction of blood flow from the mesenteric vasculature. Some areas - rectosigmoid junction & splenic flexture - are more prone to ischemia due to less collateral blood supply. If colonic infarction develops, it can lead to peritonitis, sepsis, gangrene. Present with _acute abdominal pain_ followed by diarrhea and mild rectal bleeding. Patients are often elderly and have CV risk factors. Diagnosis by labs (anemia, high serum lactate, high WBC), CT, colonoscopy
206
Treatment for ischemic colitis
Supportive: most cases improve in 1-2 days Antibiotics: when ischemia is severe or has culminated in peritonitis. Gereal Surgery may then become involved. Address underlying CV risk factors
207
Infectious colitis: Cause, presentation, diagnosis, treatment
Organisms contaminating food and water, common in developed countries. Manifest in _acute onset_ bloody diarrhea, nausea, vomiting, fever Diagnosis: stool for infectious workup; endoscopy (rarely) Treatment: hydration, antibiotics *if diarrhea is severe*
208
Angiodysplasia: presentation, treatment
Dilated, tortuous submucosal bleeds, spider-like appearance. Associated with end-stage renal disease, aortic stenosis, and advanced age. Common in the cecum and right colon. Does not typically manifest in bleeding, but if it is does, bleed is slow and occult. Treatment: endoscopy with argon plasma coagulation
209
Colon Cancer Presentation, course, management
Responsible for 10% of lower GI bleeds in patients over 50 yrs. Presents as a low grade chronic bleed. May be bright red blood if lesion is left sided or maroon stools/melena if right sided. Most commonly presents with _occult iron deficiency_. Patients may experience altered bowel habits. May lead to bowel obstruction or metastasis. _Management_: Surgery. Endoscopic treatment not ideal because tumours are highly friable (will just bleed)
210
Initial management of a GI bleed and evaluation of cause
1. ABCs: airway, breathing, circulation 2. IV setup 3. Monitory closely 4. Fluid resucitation and prepare blood for transfusion in case it is needed evaluation of cause: * History: symptoms, type of bleed, medications, liver disease, upper GI bleed * Vitals: assess level of blood loss * Assess mental status * Digital rectal exam
211
How may a large upper GI bleed be identified in blood work
elevated blood urea to creatinine ratio (ACR) because of elevated urea.
212
Colonoscopy for GI bleed
Can investigate and treat at same time. But patient needs to be stable and have their bowel prepped (polyethylene glycol). Enema only cleanses left colon and refluxes blood up, making it hard to identify source. If a brisk bleed is expect, EGD can be done as well (microclips applied that are pooped out later).
213
Role of imaging for diagnosing GI bleed
Can diagnose bleeding throughout the GIT. Quick and no need for bowel prep. A better option for patients who are unstable or the bleed wasn't foudn on colonoscopy. Options: RBC scan, CT angiography, angiography
214
What is an RBC scan?
Technetium tagged RBCs or sulfur colloid injected and then repeat XR taken for up to 24 hr. Non-invasive, sensitive for bleeding 0.1mL-0.5mL/min. Disadvantage: requires active bleeding and not good at localizing source due to persitalsis. High false positive rate that leads to unnecessary surgeries.
215
CT angiography
Contrast enhanced CT scan. Widely available, fast, non-invasive. Sensitive - detects bleeds of 0.3-0.5mL/min. Disadvantages: IV contrast, radiation exposure, lack of therapeutic capability.
216
Angiography
Performed by an interventional rediologist. For pt who can't do endoscopy or it wasn't diagnostic. Requires active bleeding of 0.5-1mL/min. Can stop bleed during the test. No need for bowel prep. May cause complications such as bowel ischemia, renal failure, rebleeding, not widely available. Need general surgery involved
217
Epidemiology of Irritable Bowel Sydrome and impact on the patient, society, health care
* May be present in 15-20% of adults (only 20% present to health care) * More common in women and middle aged * Accounts for 12% of primary care visits and 25-40% of GE referrals. * Huge impact on pt due to investigations, interventions, psychosocial distress * Huge burden on health care and economy due to missed work and disbaility
218
Presentations of IBS
* huge variability in presentation * constipation, pain, diarrhea * Extraintestinal manifestations: * Gynecologic: dymenorrhea, dyspareunia * Urologic: dysuria, frequent urination * MSK: fibromyalgia * Psychological: depression, anxiety, abuse (risk factor)
219
Pathophysiology of IBS
* *Motility disturbance _and_* *Visceral hypersensitivity* * *​*Normal perception of abnormal motility OR abnormal perception of normal motility * *dysregulation in **gut-brain axis*** : increased perception of visceral pain and altered secretomotor function * Multifactorial etiology * Microbiome imbalance * Psychological stress, smoking, diet * Genetics * Often psychological comorbities (anxiety, depression, somatization)
220
Alarm symptoms for IBS pts (5)
- new onset over age 50 - significant wt loss - GI bleeding - Fever - Nocturnal bowel movements
221
How may fibre be implicated in pathophysiology of IBS?
Normally, fibre acts to bulk stool and accelerate transit time. In IBS, fibre may be fermented into short-chain FAs and gas. Gas causes pain, bloating and flatulence. FAs result in increased osmotic load, decreased pH, changes to microbiome and possible inflammation and permeability of gut.
222
Treatment for IBS
1. Dialogue 2. DIet * Regular meals, time time and eat slow, good fluid intake * Limit fats, fizzy drinks, caffeine, sugar-free sweets, fruits * Specific food avoidances when specific intolerance is identified (lactose, gluten, fructose) 3. Drugs (variable, based on symptoms)
223
FODMAPs
Fermentable Oligosaccharaides DIsacharaides Monosaccharaides and Polyols Fermented by gut bacteria to produce gas and short chain FAs, leading to distension and diarrhea.
224
Drug therapy for IBS
Chosen based on symptoms * _Diarrhea_ * absorbants * GI relaxants * _Constipation_ * Fibre supplements, Osmotic laxatives, GI stimulants, Pro-secretory * _Pain/Bloating_ * _​_Anxiolytics, antispasmodics, anti-gas, SSRIs, TCA, pro-secretory * Others... ***CBT/psychotherapy very effective but expensive***
225
3 kinds/families of laxatives
Bulk Osmotic Stimulant (contact)
226
General function of **bulk** laxatives, indications, contraindications, SEs.
Dietary fibre through altered intake (food or supplement). Introduce indigestible, water-absorbing molecules that pull water into the gut, therbey bulking up stool. Intestinal distension leads to ENS stimulation of peristalsis. Used to treat constipation. Do not use if GI blockage is suspected - could exacerbate the problem. SE: flatulence/hypersensitivity
227
Function of **osmotic laxatives**
Osmotic laxatives are poorly absorbed salts and sugars that ast to retain or draw back waterinto the colon by osmosis. Increased distension leads to stimulation of peristalsis. Some (lactulose, glycerin) have additional effectiveness as stool softeners.
228
When may use of an osmotic laxative be indicated? Contraindicated?
Indicated in constipation or for bowel evaculation prior to a GI examination. Contraindicated in case of known or suspected GI blockage
229
Side effects of osmotic laxatives
Electrolyte imbalance (salts only) bloating and/or flatulence, abdominal cramps, and/or diarrhea
230
Stimulant/contact laxatives: example MOA pharmacokinetics SIde effects
Ex: Sennosides aka Senna MOA: Direct stimulation of myenteric plexuses in ENS resulting in smooth muscle motility and evacuation of contents. Pharmacokinetics: Minimal systemic absorption. May require enteric coating to get through stomach. Side effects: Craming and/or diarrhea; pigmentation of the colon (=melanosis coli)
231
Indications and contraindications for Senna
Indications: Constipation Contraindications: Known or suspected GI blockage. Other cotnact laxatives unsafe in pregnancy.
232
example of an osmotic laxative
PEG3500
233
example of a stimulant/contact laxative
Senna
234
Stool Softeners
Also known as emollients (i.e., glycerin, docusate). Oral and rectal formulations. MOA: Increase lubrication of feces. Mostly lubricates surface, some core penetration. Soften fecal matter to reduce effort of excretion. SE: rectal irritation Contraindications: known or suspects GI blockage
235
Opioid receptor antagonists
Selective competitive block of mu-pioid receptors (ex: methynaltrexone). Re-establish GI mobility that may have been blocked by opioid use. Indicated for pt experiencing opioid-related constipation. Administered subcutaneously. Does not readily fross BBB, so minimal effect on opioid-induced analgesia. May cause abdominal pain or cramping, diarrhea/flatulence, or nausea. Contraindicated in case of known or suspected GI blockage.
236
Treatment for opioid-induced constipation
Try laxatives and stool softeners first, followed by peripherally-active, mu-opioid receptor antagonists if the first line treatment doesn't work.
237
Diarrhea - theory of treatment
Depends on severity of contition, the cause, and the pt nutritional/health status. Non-pharm therapy: diet changes and supportive management until resolution (fluid and electrolyte supplementation) Pharmacological: Antimotility agents (Loperamide)
238
Loperamide
A selective mu-opioid receptor agonist (antimotility agent). MOA: inhibits ENS activity, increasing colonic transport time, allowing more time for water absorption. Pharmacokinetics: Doesn't readily cross BBB, and that which does has high affinity for P-glycoprotein transporter, which swiftly effluxes the drug. Does not appear to produce tolerance with chronic use. SE: constipation Indicated for use in acute, non-infectious diarrhea, chronic diarrhea. Contraindicated if use of the drug results in worsened diarrhea
239
Bismuth subalicylate
Pepto Bismol! Can treat diarrhea by reducing intestinal PGs, resulting in reduced smooth muscle contraction (motility) and reduced chloride secretion (decrease liquid). Also antimicrobial effects.
240
Theory of treatment for IBD
* symptomatic relief (pain, diarrhea) * nutrient supplementation * reduce inflammatory response
241
Pharmacotherapy for IBD
* Reduce inflammatory activity * aminosalicylates * glucocorticoids * immunosuppressants * anti-TNF alpha therapy * anti-integrin therapy treat according to severity of disease, responsiveness to each line of treatment and induction or maintenance of remission.
242
5-ASA
An aminosalicylate: Anti-inflammatory – NSAID-like inhibition of PGs, interference with cytokine production, reduced leukocyte activity
243
Contraindications for administration of prednisone
All glucocorticoids should be avoided in pt with peptic ulcer disease, heart disease, HTN with heart failure, or osteoporosis
244
245
Aldosterone upregulatres which channel in the gut?
ENaC in the distal colon and rectum